Edition:
United Kingdom

People: OncoTherapy Science Inc (4564.T)

4564.T on Tokyo Stock Exchange

111JPY
19 Jul 2019
Change (% chg)

¥0 (+0.00%)
Prev Close
¥111
Open
¥112
Day's High
¥112
Day's Low
¥110
Volume
271,400
Avg. Vol
903,355
52-wk High
¥175
52-wk Low
¥105

Fujiya, Kyoko 

Ms. Kyoko Fujiya was named President and Representative Director in OncoTherapy Science, Inc., as well as President and Representative Director of a subsidiary, Cancer Precision Medicine, Inc., effective January 23, 2019. Her previous titles include Executive Officer and Senior Director of Business in the Company. She used to work for GE Healthcare Japan Corporation and another company. She obtained her Bachelor's degree in English from Shibuya Institute of Foreign Languages in March 1986, and her Bachelor's degree in Management Information from SANNO UNIVERSITY in September 2003.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --